Back to Journals » Cancer Management and Research » Volume 14

Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway [Retraction]

Authors Guo L, Yang T

Received 29 July 2022

Accepted for publication 29 July 2022

Published 2 August 2022 Volume 2022:14 Pages 2289—2290

DOI https://doi.org/10.2147/CMAR.S384253



Guo L, Yang T. Cancer Manag Res. 2019;11:10499–10508.

At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns that several migration and invasion images in Figure 4 had been duplicated. Specifically,

  • Figure 4A, MCF-7, 30 µM appears to have been duplicated with the same image for Figure 4B, MCF-7, 30 µM.
  • Figure 4B, MCF-7, DMSO appears to have been duplicated with the same image for Figure 4B, MCF-7, 10 µM.
  • Figure 4C, MDA-MB-231, DMSO appears to have been duplicated with the same image for Figure 4D, MDA-MB-231, 30 µM.
  • Figure 4C, MDA-MB-231, 10 µM appears to have been duplicated with the same image for Figure 4C, MDA-MB-231, 30 µM; Figure 4D, MDA-MB-231, DMSO and Figure 4D, MDA-MB-231, 10 µM.

The authors were unable to provide a satisfactory explanation for how the images came to be duplicated, nor were they able to provide the original data for their study. The Editor agreed with the authors request to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.